FLAVAMED 15mg/5ml syrup syrup BERLIN CHEMIE
ambroxol Indicated for: respiratory disorders with viscous secretions
R05CB06 Respiratory system | Expectorants, excl. combinations with cough suppressants | Mucolytics
letter F · page 20
ambroxol Indicated for: respiratory disorders with viscous secretions
R05CB06 Respiratory system | Expectorants, excl. combinations with cough suppressants | Mucolytics
ambroxol Indicated for: respiratory disorders with viscous secretions
R05CB06 Respiratory system | Expectorants, excl. combinations with cough suppressants | Mucolytics
ambroxol Indicated for: respiratory disorders with viscous secretions
R05CB06 Respiratory system | Expectorants, excl. combinations with cough suppressants | Mucolytics
ambroxol Indicated for: respiratory disorders with viscous secretions
R05CB06 Respiratory system | Expectorants, excl. combinations with cough suppressants | Mucolytics
ambroxol Indicated for: respiratory disorders with viscous secretions
R05CB06 Respiratory system | Expectorants, excl. combinations with cough suppressants | Mucolytics
ambroxol Indicated for: respiratory disorders with viscous secretions
R05CB06 Respiratory system | Expectorants, excl. combinations with cough suppressants | Mucolytics
plants Indicated for: herbal symptomatic treatment
R02AA20 Respiratory system | Throat preparations | Throat preparations | Antiseptics
Ginkgo biloba Indicated for: cognitive disorders; peripheral vascular disease
Ginkgo biloba Indicated for: cognitive disorders; peripheral vascular disease
Ginkgo biloba Indicated for: cognitive disorders; peripheral vascular disease
diosmin Indicated for: chronic venous insufficiency; capillary fragility
C05CA53 Cardiovascular system | Capillary stabilizing agents | Bioflavonoids
diosmin Indicated for: chronic venous insufficiency; capillary fragility
C05CA03 Cardiovascular system | Capillary stabilizing agents | Bioflavonoids
azelastine + fluticasone Indicated for: allergic rhinitis
diosmin Indicated for: chronic venous insufficiency; capillary fragility
C05CA03 Cardiovascular system | Capillary stabilizing agents | Bioflavonoids
diosmin Indicated for: chronic venous insufficiency; capillary fragility
C05CA03 Cardiovascular system | Capillary stabilizing agents | Bioflavonoids
hydrocortisone Indicated for: inflammation; adrenal insufficiency
normal immunoglobulin for intravascular administration Indicated for: immunosuppression
J06BA02 Antiinfectives for systemic use | Immunoglobulins | Immunoglobulins, normal human
normal immunoglobulin for intravascular administration Indicated for: immunosuppression
J06BA02 Antiinfectives for systemic use | Immunoglobulins | Immunoglobulins, normal human
normal immunoglobulin for intravascular administration Indicated for: immunosuppression
J06BA02 Antiinfectives for systemic use | Immunoglobulins | Immunoglobulins, normal human
normal immunoglobulin for intravascular administration Indicated for: immunosuppression
J06BA02 Antiinfectives for systemic use | Immunoglobulins | Immunoglobulins, normal human